CHAD Therapeutics, Inc. (CHAD) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$9.99

From 52W high+0.00%

Volume18740.00

Market cap$326.21M

P/E (TTM)—

P/S (TTM)—

Div yield2.07%

Key dataNov 4, 2026

Open

$9.99

From 52W high

+0.00%

Volume

18740.00

Market cap

$326.21M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

61.7

MomentumView details →

1D Return

+0.06%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+0.06%

YTD Return

—

1Y Return

—

RSI (14)

61.7

vs 50D SMA

—

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

2.07%

Div Rate

$0.21

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsNov 12, 2026 →

Latest newsMore news →

No recent news for CHAD.

Similar companies

Roman DBDR Acquisition Corp. IIDRDB Cantor Equity Partners Vii Inc.CAES Columbus Circle Capital Corp II Class AIPXG Safeguard Acquisition Corp.SAC China Success Finance Group Holdings Limited03623.HK Abony Acquisition Corp. I Class A Ordinary ShareAACO Find similar companies →

Latest newsMore news →

No recent news for CHAD.